More
    - Advertisement -

    Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine

    -

    - Ad Keep reading below -

    The pricing for the United States was in line with the cost of seasonal flu vaccines and much less expensive than vaccines for conditions like shingles, which can run into several hundred dollars.

    “That price point does not seem offensive, even if you don’t spend a lot of time thinking about prescription drugs,” said Stacie Dusetzina, an associate professor of health policy at Vanderbilt University Medical Center. “Just thinking about any prescription you’d fill, you’d be hard-pressed to find pretty much anything for $20.”

    - Ad Keep reading below -

    But the fact that Pfizer appears to have earned something like $900 million in pretax profits from its vaccine — coupled with its comparatively small sales to poor countries — suggests that profits have trumped other considerations. That could undercut the company’s embrace of loftier principles.

    “At Pfizer, we believe that every person deserves to be seen, heard and cared for,” the chief executive, Albert Bourla, said in January as the company announced it would join Covax. “We share the mission of Covax and are proud to work together so that developing countries have the same access as the rest of the world.”

    ALSO READ  Fertilizer importation ban: Buhari’s decision best for Nigeria – FEPSAN boss, Etuh
    - Ad Keep reading below -

    But the company seems to have prioritized higher-priced sales.

    ALSO READ  Fertilizer importation ban: Buhari’s decision best for Nigeria – FEPSAN boss, Etuh

    “Despite all the talk about Covax, they have been far more interested in bilateral deals, because that’s where they make their money,” said Richard Kozul-Wright, director of the division on globalization and development strategies at the United Nations Conference on Trade and Development in Geneva. “It’s one of the great public relations triumphs of recent corporate history.”

    Multiple factors explain the inequitable nature of Pfizer’s vaccine distribution.

    The shot, which must be stored and transported at very low temperatures, is less practical for hard-to-reach parts of the world than other shots, like those from AstraZeneca and Johnson & Johnson, that can simply be refrigerated. Some poor countries were initially not hit hard by the virus, and so their governments had less urgency to place orders for the Pfizer vaccine, to the extent that they could afford to pay for the shots.

    ALSO READ  Milioni 150 zajenga bwalo Nyasa
    - Ad Keep reading below -

    “Not everyone was interested in the vaccine or prepared to take steps; thus, conversations continue, including working with Covax beyond their initial order of 40 million doses,” said Ms. Castillo, the Pfizer spokeswoman.

    ALSO READ  China yapinga vikali shutuma za ''mauaji ya kimbari''
    - read any article below now-

    Latest news

    Shocking Leicester display raises serious questions about ability to handle pressure

    Leicester's top-four hoodoo returned as they collapsed in the 4-2 loss to Newcastle United.

    Postpone LG election to avoid another legal gymnastics – ex-Oyo Gov, Alao-Akala tells Makinde

    A former Governor of Oyo State, Chief Christopher Adebayo Alao-Akala, has advised the incumbent Governor, Engineer Seyi Makinde, to without wasting more time, postpone...

    FBI hails EFCC for efforts on global crime war

    The Federal Bureau of Investigation (FBI) considers the Economic and Financial Crimes Commission (EFCC) a critical partner in the global fight against organized crime...
    - Advertisement -

    You might also likeRELATED
    Recommended to you

    - Advertisement -
    %d bloggers like this: